계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
CardioKinetix
company
About
CardioKinetix is a medical device company offering the Parachutem, a catheter-based treatment for heart failure.
- 11 - 50
Details
- Last Funding Type
- Series E
- Last Funding Money Raised
- $23M
- Industries
- Biotechnology,Health Care,Medical Device
- Founded date
- Jan 1, 2003
- Number Of Employee
- 11 - 50
- Operating Status
- Active
The Company, based in Menlo Park, has developed a novel transcatheter implant called the PARACHUTETM Ventricular Partitioning Device (PARACHUTETM). The PARACHUTETM intends to treat heart failure resulting from a heart attack or myocardial infarction in millions of patients worldwide by improving overall cardiac function.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$37.50M
CardioKinetix has raised a total of
$37.50M
in funding over 2 rounds. Their latest funding was raised on
Mar 1, 2013 from a Series E round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 1, 2013 | Series E | $23M | 1 | — | — | Detail |
| Jul 15, 2008 | Series C | $14.50M | 1 |
Cutlass Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
CardioKinetix is funded by 2 investors.
Cutlass Capital
and H&Q Healthcare Investors
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Cutlass Capital
|
Yes | Series C |
|
|
— | Series E |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
